BN Agrochem Regulatory Approval

ED Probe / Tax Survey

BN Agrochem ED Probe / Tax Survey

BN Agrochem disclosed an Income Tax Department search at its premises from 22 to 27 October 2026. The company states no seizure, normal operations and full cooperation.

Annual General Meeting

BN Agrochem Annual General Meeting

BN Agrochem's first EGM for FY 2026-27 has been adjourned due to lack of quorum. The rescheduled meeting is set for October 29, 2026.

Price Movement Clarification

BN Agrochem Price Movement Clarification

BN Agrochem clarified to BSE that no undisclosed material event caused the recent price movement. The company confirmed no pending price-sensitive information requiring disclosure.

Acquisition

BN Agrochem Acquisition

BN Agrochem Ltd received an NCLT order granting a 90-day extension to convene shareholder and creditor meetings related to its ongoing Scheme of Amalgamation.

Stock Split

BN Agrochem Stock Split

BN Agrochem Limited's board has approved a 1:10 stock split, sub-dividing shares from face value ₹10 to ₹1. An extraordinary general meeting is scheduled for October 22, 2026.

Other Announcement

BN Agrochem Other Announcement

BN Agrochem Ltd has changed its official website domain from www.bn-holdings.com to https://www.bnagrochem.com. This administrative update is effective immediately.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.